Aarti Drugs Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹702.78 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.43 per cent from ₹720.30 crore. This corresponds to a year-on-year *(YoY) growth of 19.01 per cent.
Operating Profit
Operating Profit stands at ₹96.11 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.32 per cent from ₹95.80 crore. This corresponds to a year-on-year *(YoY) growth of 29.74 per cent.
PBDT
PBDT stands at ₹87.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.79 per cent from ₹88.40 crore. This corresponds to a year-on-year *(YoY) growth of 33.22 per cent.
Profit Before Tax
Profit Before Tax stands at ₹69.24 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.59 per cent from ₹70.36 crore. This corresponds to a year-on-year *(YoY) growth of 35.47 per cent.
Net Profit
Net Profit stands at ₹50.13 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.28 per cent from ₹55.26 crore. This represents a 7.12 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Aarti Drugs Ltd Earnings
- YOY
- QOQ
Aarti Drugs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Aarti Drugs Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Aarti Drugs Ltd Financial Reports
Aarti Drugs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Aarti Drugs | 1.54% | 2.67% | 5.61% | 9.01% | 10.95% | -14.59% |
| Gufic BioScience | 3.64% | 7.50% | 8.50% | 40.16% | 34.42% | 17.14% |
| Novartis India | 0.56% | -1.12% | 10.08% | 35.93% | 91.66% | 72.86% |
| Guj. Themis Bio. | -2.35% | -0.69% | -5.80% | -8.83% | 4.77% | 0.48% |
| Advanced Enzyme | -1.72% | 0.48% | 0.18% | -16.73% | 11.72% | 8.23% |
| SMS Pharma. | 6.08% | 3.96% | -6.94% | -9.86% | 18.06% | 64.34% |
| Unichem Labs. | -1.14% | -3.50% | -25.16% | 27.87% | 21.97% | -1.07% |
Company Info
Company Information
CMD & Executive Director : Prakash M Patil
ED / MD / Promoter : Rashesh C Gogri
ED / Joint MD / Promoter : Harshit M Savla
E D & Wholetime Director : Harit P Shah
WTD & Executive Director : Uday M Patil
Non Executive Director : Narendra Jagannath Salvi
Independent Non Exe. Director : Ankit Vikram Paleja
Independent Non Exe. Director : Bhaskar Narayan Thorat
Independent Non Exe. Director : Neha Gada
Independent Non Exe. Director : Hasmukh Dedhia
Independent Non Exe. Director : Sandeep Madhusudan Joshi
Independent Non Exe. Director : Shri Ajit E. Venugopalan
Company Sec. & Compli. Officer : Rushikesh V Deole
Chairman Emeritus : Chandrakant V. Gogri